Next-gen CyTOF Aliri Bioanalysis recently launched a next-generation CyTOF assay for single-cell profiling, signaling a capability expansion that can address pharma and biotech needs for high-resolution immune and cellular analyses.

Bioanalysis & Spatial The company offers integrated bioanalysis, spatial bioanalysis, and spatial biology solutions, presenting cross-selling opportunities to customers seeking comprehensive data for lead optimization and regulatory submissions.

Mid-market Focus With revenue in the multi-tens of millions and a headcount around 51-200, Aliri sits between smaller CROs and large contract research firms, suggesting potential for tiered service packages and scalable partnerships.

Regulatory Enablement Aliri emphasizes speeding therapies to market and strengthening regulatory submissions, presenting a pathway to align service offerings with clients’ regulatory milestones and submission timelines.

Tech Stack Readiness Utilizing Salesforce, OneTrust, and other modern tools, Aliri is positioned to scale customer relationship management, compliance, and data governance, enabling targeted outreach and efficient onboarding for new clients.